UPDATE: Editas shares boosted as patent office rules in favo

The U.S. Patent and Trademark Office has ruled in favor of the Broad Institute of MIT and Harvard in a dispute over the patents around CRISPR gene editing technology.

Related Keywords

, Ineditas , Crispr Cas9 , Broad Institute Of Mit And Harvard , Patent Challenge , Gene Editing , Rispr , Cell Amp Gene Therapy , Iotech Patent News , University Of California , Biotech , Fierce Biotech Homepage ,